Uncategorized
Candida auris Persists in Hair Follicles, Hijacks Immune Signaling
Since its discovery in 2009, Candida auris—a multidrug-resistant pathogenic yeast—has caused deadly outbreaks around the world and is responsible for roughly 3,000 deaths in patients in hospitals and long-term care facilities per year in the U.S. The fungus is known to colonize human skin, however, the mechanisms that it uses to persist on skin remain unclear.
To understand the mechanisms C. auris uses to colonize the skin, a team of researchers compared it with Candida albicans—a common skin fungus that the immune system normally clears quickly. The team used mouse models, fungal and mouse genetics, immunology, single-cell RNA-seq, and volumetric quantitative confocal microscopy. In mice, C. albicans disappeared within days, but C. auris persisted, taking refuge in hair follicles.
This work is published in Science in the paper, “The fungal pathogen Candida auris exposes chitin to trigger IFNg and persist in hair follicles.”
“Candida auris colonizes skin way better than most other fungi, setting it up to invade once the immune system is weakened,” said Dean Merrill, MD, a dermatologist and professor at UCSF. “The big clinical problem is that we have no effective way to remove it from the skin.”
The researchers discovered not only that C. auris colonized mouse skin with higher titers and greater persistence than C. albicans—exhibiting direct hair-binding activity and a strong tropism to hair follicles—but also that the two produced very different immune responses.
More specifically, they write, “Whereas C. albicans elicited a host-protective type 3/17 skin immune response driven by interleukin-17A (IL-17A), as previously described, C. auris triggered a type 1–skewed immune response, characterized by hair follicle–associated expansion of type 1 conventional dendritic cells (cDC1), type 1 cytotoxic T cells (Tc1), and T helper 1 immune cells (Th1), as well as increased interferon-γ (IFNγ) production. IFNγ signaled directly to hair follicle keratinocytes, reducing the expression of genes and downstream programs driven by IL-17A and associated with skin barrier function and antimicrobial defense.”
The team also used mice with defects in cytokine signaling to establish that IFNγ “promoted the persistence of C. auris in the epidermal niche while maintaining its classic host-protective role during deeper skin or blood infections.”
The C. auris remodels its exterior cell wall to expose more chitin, which spurs immune cells to release interferon gamma around the hair follicle. The interferon gamma blocked the skin’s antifungal defenses, including IL-17. It also slowed the natural replacement of hair follicle cells, leading to a buildup of older, damaged cells—a niche where C. auris could flourish.
“Chitin is widespread in nature, so it’s not like the human skin never encounters it, but we were surprised to see that C. auris actively uses its chitin to turn the skin into a perfect nest,” said Suzanne Noble, MD, PhD, professor of microbiology at UCSF.
The findings reveal potential targets for preventing C. auris from persisting on the skin. One approach could involve drugs that tilt the immune system away from interferon gamma signals and toward IL-17, which drives the skin’s normal antifungal clearing process. Or perhaps drugs that block chitin could prevent the fungus from amplifying the interferon gamma signals. More broadly, the researchers say the work offers a new way to think about how microbes can quietly coexist with us before becoming pathogenic.
The post <i>Candida auris</i> Persists in Hair Follicles, Hijacks Immune Signaling appeared first on GEN – Genetic Engineering and Biotechnology News.
Uncategorized
New webinar: Tackling drug discovery challenges in cancer research

Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development.
You will hear from Dr Sudha Rao, Chief Scientific Officer of Kazia Therapeutics, Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics and Lars van der Veen, Chief Scientific Officer at iOnctura.
Presentations will cover how cancer treatments have shifted towards reprogramming the biology driving tumour growth, immune escape and treatment resistance, the trajectory that in vivo CAR-T treatments are taking, and how challenging tumours burdened by stroma and immune-mediated resistance can be tackled.
Q&A with the speakers follows the presentations.
The post New webinar: Tackling drug discovery challenges in cancer research appeared first on Drug Discovery World (DDW).
Uncategorized
Psilocybin proves promising in neuropathic pain mouse study
Amid the rise of psychedelics in the mental health space, researchers have begun to explore psilocybin as a treatment for chemotherapy-induced peripheral neuropathy.
Uncategorized
New Spectrometry Technique Could Aid Formulation Development
New Spectrometry Technique Could Aid Formulation Development
A new technique combining two forms of spectrometry could help biopharmaceutical companies improve their choice of formulation buffer for antibody manufacturing by revealing how molecular forms and three-dimensional shapes of complex biologics respond to their environment. That’s the view of Christian Bleiholder, PhD, a professor at Florida State University who helped develop the technique.
According to Bleiholder, what happens structurally when a complex biological molecule, such as an antibody or viral spike protein, binds to its target is currently poorly understood.
“This is where [this approach] can help with the bioprocessing and formulation,” he says, as structural changes “can affect the lifespan [of the product] and lead to issues, such as aggregation.”
Because antibodies are complex, existing techniques tend to be powerful at different levels of complexity, he explains. Mass spectrometry is particularly powerful for distinguishing molecular composition, while structural approaches such as X-ray crystallography and cryo-electron microscopy can provide high-resolution structural information.
The challenge is understanding the link between these things within a heterogeneous sample, he says.
To overcome this, Bleiholder and his team worked with Bruker Daltonics to develop Tandem-Trapped Ion Mobility Spectrometry (Tandem-TIMS). This combines tandem ion mobility spectrometry with tandem mass spectrometry to disentangle three overlapping layers of molecular complexity: molecular form, three-dimensional shape, and binding or assembly state, he says.
He explains that, if the proteins have different structures, they can be characterized with tandem ion mobility spectrometry, and then mass spectrometry can be used to look at their molecular forms and binding states.
Going forward, Bleiholder hopes the technique can be used for formulation development but also earlier, during drug discovery of new products, such as multi-specific antibodies, to determine which molecular states are important and how those change when a biologic engages its target. He also plans to look at automating the technique.
Bleiholder spoke about using Tandem-TIMS at the Bioprocessing Summit in Boston earlier this year.
The post New Spectrometry Technique Could Aid Formulation Development appeared first on GEN – Genetic Engineering and Biotechnology News.
-
Uncategorized8 months agoNovartis buys Synnovation’s PI3Kα inhibitors for $3 billion
-
Endpoints News8 months ago
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
-
Uncategorized7 months agoOptical Pooled CRISPR Screen Reveals Regulators of NF-κB Dynamics in Human Cells
-
Uncategorized6 months ago
Relay’s PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies study
-
Uncategorized6 months ago
Hybrid solid−liquid optics enable scalable, high-resolution light-sheet microscopy across diverse immersion media
-
Fierce Biotech8 months ago
Scientists turn pig semen extract into eye drops that kill cancer in mice
-
Nature Biotechnology8 months ago
Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy
-
Nature Biotechnology8 months ago
Mapping cis-regulatory mutations at scale in sorghum enables modulation of gene expression
Scan to Read